Jonathan Goodwin

Jonathan Goodwin is a Ph.D. scientist and the Director of Early Discovery at ARTBIO, where they focus on advancing the next generation of ARTs for cancer treatment. They earned their Doctor of Philosophy in Biological Sciences from the University of California, San Diego, and previously worked as a Postdoctoral Fellow at Novartis Institutes for BioMedical Research, where they discovered unique lysosomal targeting pathways. Their extensive experience includes roles at DEM Biopharma, Inc., Casma Therapeutics, and Massachusetts General Hospital, emphasizing target discovery and functional genomics. Jonathan's strong communication skills and deep understanding of signaling pathways in human disease contribute to their reputation as a creative leader in the biotech industry.